Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

8,537

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

8,537 results for “Openness”

Learn how ShareScore rates datasets ↗
zenodo12/100

Open Data sets from Cold Climate Wind Farms in Finland, Olostunturi

<p>This dataset includes 6 years of open access meteorological mast data and operational data of multiple turbines&nbsp;from Olos wind farm&nbsp;in Finland, and simultaneous and longer-term monthly icing time series from WIceAtlas database for reference. Olos is a complex terrain site with severe icing conditions during winter (IEA Ice Class 4).</p> <p>The work was funded by an EU IRPWIND project.</p>

restrictedFeb 2018View details →
zenodo12/100

geodatabase for open space points

Open the record for dataset details and reuse information.

restrictedcc-by-4.0Sep 2024View details →
zenodo12/100

RxTrends: An R Shiny Application for Visualising Open Data on Prescribed Medications in Ireland

Open the record for dataset details and reuse information.

restrictedcc-by-4.0Oct 2024View details →
zenodo12/100

Open 1.0-T versus closed 1.5-T cardiac MR: Image quality assessment

<p>Dataset from&nbsp;Al&igrave; M, Monti CB, Gold B, Lastella G, Papa S, Sardanelli F, Secchi F. Open 1.0-T versus closed 1.5-T cardiac MR: Image quality assessment. Clin Imaging. 2020 Dec;68:102-107. doi: 10.1016/j.clinimag.2020.06.019. Epub 2020 Jun 15. PMID: 32585415.</p> <p><strong>Abstract</strong></p> <p><strong>Purpose:&nbsp;</strong>The aim of this paper was to compare the open 1-T (O-1T) versus the closed 1.5-T (C-1.5T) cardiac magnetic resonance (MR).</p> <p><strong>Patients/methods:&nbsp;</strong>The MR examinations of two concurrent cohorts (each including 100 subjects) of patients with suspected or known cardiac disease were reviewed. Such examinations were obtained using O-1T or C-1.5T MRI. The bright-blood cine, T1-weighted (T1), T2-weighed short-tau inversion recovery (T2-STIR), late gadolinium enhancement (LGE) sequences were performed. Signal-to-noise ratio of blood (SNRb) or myocardium (SNRm), and contrast-to-noise ratio of myocardium (CNRm) were calculated. Subjective image quality (SIQ) of each sequence was graded as 0 = poor, 1 = intermediate, or 2 = optimal. Each examination was considered as diagnostic when the report answered the clinical question.</p> <p><strong>Results:&nbsp;</strong>C-1.5T was better than O-1T on cine for SNRb(median 172 versus 452), SNRm(71 versus 160) and CNRm (107 versus 265) and on T2-STIR for SNRb(10 versus 29), SNRm(74 versus 261) and CNRm(-67 versus -233)(P &lt; 0.001). On LGE, SNRm was higher with O-1T than for C-1.5T (312 versus 79, P &lt; 0.001) while CNR was lower (158 versus 389; P &lt; 0.001). No significant differences were found for SNRb on LGE and both SNRm and CNRm on T1 (P &ge; 0.215). SIQ of O-1T was not significantly different from that of C-1.5T for both R1 and R2 for cine, T1, and LGE (P &ge; 0.157); for T2-STIR, SIQ of O-1T was significantly lower (P = 0.003). R1-R2 concordance was almost perfect (&kappa; = 0.816-0.894), and all examinations were diagnostic.</p> <p><strong>Conclusion:&nbsp;</strong>Even though quantitative measurements mostly favored C-1.5T, the SIQ of O-1T was not significantly different for any sequence, with the only exception of T2-STIR.</p>

restrictedJul 2021View details →
zenodo12/100

Receiver Function Open-Access Dataset for the European Alps

<p>This dataset comprises of the receiver function traces calculated using&nbsp;seismic waveform data from the <a href="http://www.alparray.ethz.ch/en/home/">AlpArray Seismic Network</a>,&nbsp;three other temporary seismic networks, and permanent stations in the broader European Alpine region. We use this dataset to compile a new Moho depth map for the broader European Alps.</p> <p>In particular, we include:</p> <ol> <li>the radial receiver function traces in .SAC format (RRF.zip). One SAC trace per station and teleseismic earthquake.&nbsp;</li> <li>the&nbsp;transverse&nbsp;(TRF.zip) traces in .SAC format.&nbsp;</li> <li>the receiver function stacks from all the seismic stations plotted versus back-azimuth in .png format&nbsp;(RRF_plots.zip and TRF_plots.zip)</li> </ol> <p>For details on how to read and process the receiver function traces have a look at the README file of the repository.</p>

restrictedNov 2022View details →
zenodo12/100

A THREE-DIMENSIONAL (3D) COMPARATIVE ASSESSMENT OF THE DENTOSKELETAL EFFECTS OF CLEAR ALIGNERS VERSUS TEMPORARY ANCHORAGE DEVICE (TAD)-ASSISTED POSTERIOR INTRUSION IN ADOLESCENTS WITH ANTERIOR OPEN BITE. A SINGLE-CENTER, RETROSPECTIVE, COHORT STUDY.

<p>Anterior Open Bite (AOB) is a malocclusion characterised by the absence of overbite and contact between upper and lower incisors in centric occlusion. AOB prevalence worldwide has been reported to be approximately 5-6%, with a higher occurrence in certain ethnic groups. Management of AOB malocclusion in growing patients varies and the armamentarium of conventional clinical practice includes habit cessation devices such as tongue crib and spurs, activators, and removable or fixed posterior bite blocks aimed at controlling tongue posture and posterior eruption respectively.&nbsp;Alternative methods for the correction of AOB include intrusion of posterior teeth using skeletal anchorage through temporary anchorage devices (TADs) and clear aligner therapy (CAT).&nbsp;The current literature indicates that TAD assisted molar intrusion induces open bite closure through mandibular counter-clockwise rotation of up to 3.9<sup> </sup>degrees.&nbsp;It has been suggested that clear aligners produce changes in the vertical dimension through a bite-block effect, facilitating counter-clockwise autorotation of the mandible and improving skeletal open bite. A recent study on adult patients concluded that reductions in AOB with CAT are largely a result of 1mm maxillary and mandibular incisor extrusion with some increases also noted in their lingual inclination, particularly in the maxilla.&nbsp;Most studies to date rely on two-dimensional (2D) cephalometric analyses of AOB treatment in both non-growing and adult patients.&nbsp;The aim of the present study was to compare the skeletal and dentoalveolar effects of CAT versus TAD-assisted intrusion of maxillary posterior teeth in growing adolescents with AOB using three-dimensional (3D) imaging. The null hypothesis assumed that there were no statistically significant differences in skeletal and dentoalveolar changes between the two groups. Additionally, the occlusion of the CAT group was assessed with the American Board of Orthodontists Objective Grading System (ABO-OGS) in order to provide evidence of the quality of final occlusion achieved with CAT.</p>

restrictedNov 2022View details →
zenodo12/100

BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm

<p>The database is related to the article &ldquo;BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm&rdquo;. In this database we reported all the clinical and anamnestic data of the patients who completed the trial (e.g. 32 high-frequency episodic migraine subjects and 28 of them completed the trial).&nbsp; After a 28-day baseline period, subjects underwent 4 subsequent onabotulinum toxin-A treatments according to the phase III research evaluating migraine prophylaxis therapy (PREEMPT) paradigm, 12-weeks apart. Onabotulinum toxin-A reduced monthly migraine days by 3.68 days. Thirty-nine percent of the patients experienced a &ge;50% reduction in monthly migraine days. Onabotulinum toxin-A also reduced the number of headache days and the intake of acute medications. Disability and quality of life (QoL) scores improved markedly.</p>

restrictedApr 2022View details →
zenodo12/100

Is early MIDAS reduction at 3 months the best indicator predictor for erenumab treatment continuation? A open-label trial

<p>This database includes the raw data linked with the paper &ldquo;Is early MIDAS reduction at 3 months the best indicator predictor for erenumab treatment continuation? A open-label trial&rdquo;, published on The Journal of Headache and Pain.</p> <p>&nbsp;</p> <p>In this paper, we described migraine disability, quantified as a MIgraine Disability ASsessment (MIDAS).</p> <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A moderate to severe disability, MIDAS score  11, is required for prescription.</p> <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Score reduction of at least 50% after the first three months (T3) is mandatory to continue treatment.</p> <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Primary aim of this study:</p> <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - to evaluate whether 50% MIDAS reduction at T3 (MIDASRes) is a reliable response predictor of one-year erenumab treatment (classified as a reduction of baseline MMDs 50%).</p> <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The 50% reduction of monthly migraine days (MMD) at T3 Co-primary outcome</p> <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Secondary outcomes:</p> <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - the search of other predictors represents</p> <p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</p> <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Methods:</p> <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In this prospective, open-label study, 77 CM patients (mean age 49.8&plusmn;9.5 years, chronicity history 13.1&plusmn;10.3years, 93.5% of medication overuse headache) were treated with erenumab 70-140mg subcutaneous injections every 28 days for one year (T13). We assessed demographic and headache features, monthly migraine and headache days (MMD and MHDs respectively), days and doses of symptomatic intake. Patients also completed questionnaires evaluating migraine related disability (MIDAS and HIT-6), psychological comorbidities (HADS-A and HADS-D), quality of life (MSQ and 0 to 100 visual analogue scale) and allodynia (ASC-12). ANOVA for repeated measures was performed for quantifying erenumab efficacy and logistic regression model was used for evaluating one-year predictors of response.</p> <p>&nbsp; &nbsp; &nbsp; &nbsp;</p> <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Results:</p> <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Erenumab induced a sustained reduction of MMDs, MHDs and symptomatic intake during treatment. At T13 64.9% of patients presented MMDs baseline reduction 50% (RespondersT13). At T3, 55.8% of patients were MIDASRes. Contextually, 55.4% of patients were MMD Responders, these were also more likely to qualify as RespondersT13 when compared to non-responders (83.3% vs 42.9%; p=0.001). MMD response at T3 also demonstrated to be a predictor of long-term outcome according to a multivariate analysis ((Exp(B)=7.128; p=0.001)). When MIDAS reduction at T3 is considered as decision-making predictor of long-term outcome, 36.0% of patients who may benefit from 1-year erenumab administration are early excluded. By contrast, a lower percentage of Responders T13 (16%) would be discontinued if MIDASRes or MMD responders at T3 were alternatively considered.</p>

restrictedJun 2022View details →
zenodo12/100

Perception of librarians towards adoption of Linked Open Data

<p>This dataset is associated to an article on perception of librarians towards the adoption of Linked Open Data</p>

restrictedSep 2023View details →
zenodo12/100

Dataset for "Estimation of free energy for gate opening in a series of flexible adsorbents based on adsorption observations"

<p>Supporting dataset for: &ldquo;Estimation of free energy for gate opening in a series of flexible adsorbents based on adsorption observations&rdquo;, Sebastian Ehrling, Hiroki Miura,&nbsp;Stefan Kaskel and&nbsp;Jack D. Evans,&nbsp;<strong>2023</strong></p> <p><strong>Contains:</strong></p> <ul> <li>data: adsorption isotherms in .aif, .json and .csv format</li> <li>fits: parameters for the model fits to the isotherms in .pkl and .csv format.</li> <li>notebooks: python notebooks demonstrating how the isotherms were fit, analysed for enthalpy and free energy.</li> </ul>

restrictedOct 2023View details →
ClinicalTrials.gov12/100

Prospective and Comparative Analysis of Arthroscopic and Open Surgery for Hallux Rigidus

ClinicalTrials.gov study NCT00284362. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
geo12/100

Characterization of distinct types of open chromatin and their impacts on gene transcription in maize [MH-seq]

GEO Series GSE157149. Zea mays. 2 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.

openGEO-OpenAug 2023View details →
geo12/100

A Time-dependent Glia cell-Mediated Neuroprotective Effects of Kv7/KCNQ channel opener QO-83 in Ischemic Stroke: Mechanisms of Action and Therapeutic Potential

GEO Series GSE244576. Mus musculus. 5 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenSep 2025View details →
geo12/100

Open chromatin landscape of mouse embryonic stem cells

GEO Series GSE113592. Mus musculus. 1 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.

openGEO-OpenApr 2018View details →
geo12/100

Che-1/AATF sustains cell growth and global transcription in Multiple Myeloma through the maintenance of open chromatin structure [ATAC-Seq]

GEO Series GSE100494. Homo sapiens. 2 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.

openGEO-OpenJun 2021View details →
geo12/100

Characterization of open chromatin sensitive to actin polymerization using DSP-MNase-DNA-seq

GEO Series GSE257539. Homo sapiens. 4 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.

openGEO-OpenAug 2024View details →
geo12/100

Che-1/AATF sustains cell growth and global transcription in Multiple Myeloma through the maintenance of open chromatin structure. [ATAC-Seq, mouse]

GEO Series GSE120964. Mus musculus. 7 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.

openGEO-OpenJun 2021View details →
zenodo8/100

Open Linguistic Picture Database

<p>This dataset includes 101 pictures that belong to the Open Linguistic Picture Database.</p>

restrictedDec 2019View details →
zenodo8/100

Figure 1: Open Science needs standards, training and funding

<p>Figure for Publication</p>

restrictedMay 2020View details →
zenodo8/100

Adapting Cultural Probes to an Online-Only Format to Inform the Design of Online Heritage Experiences - Open Questions Answers

<p>Answers provided by the participants to the open questions. Responses are separated by type of probe and classified by question.</p>

restrictedAug 2020View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.